Company intelligence / Profile preview
Rubicon Biotechnology
Irvine, California, United Statesrubiconbio.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Preclinical
01
Overview
Rubicon Biotechnology develops two proprietary biologic platforms. The first, Fv-Hsp72, delivers heat shock protein Hsp72 into stressed or dying cells to salvage them after acute injuries such as myocardial infarction or traumatic brain injury. The second, a modified form of annexin A5 licensed from MosaMedix B.V., targets phosphatidylserine exposed on the surface of solid tumors and their blood vessels to deliver immunostimulants directly into the tumor microenvironment. Both programs are in preclinical development with collaborations aimed at advancing toward clinical trials. The company has received industry recognition including a Merck Advance Biotech Grant for its work on Fv-Hsp72.
- Therapeutic areas
- PulmonologyCardiovascularOtherOncologyNeurology
- Modalities
- Recombinant proteins/biologics (Fv-Hsp72, Modified Annexin A5)Immunostimulants (via Modified Annexin A5)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Celltheon Expression Technologies—for cell line/process development using SMART™ Platform for Fv-Hsp72 program.Merck KGaA—recipient of Merck’s Advance Biotech Grant supporting process development for Fv-Hsp72 program.MosaMedix B.V.—licensor of modified annexin technology used by Rubicon Biotechnology.Collaborations with several leading US research institutions mentioned but not named specifically.
Beyond the preview
Go deeper on Rubicon Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rubicon Biotechnology.